Glenview, Ill. (August 4, 2015)--Researchers have found the risk for hospital readmission to be nearly three times higher after COPD exacerbation if a follow-up visit to a pulmonologist is skipped. The Israeli study published today in the journal CHEST The Association Between Hospital Readmission and Pulmonologist Follow-up Visits in Patients With COPD examined the impact of a pulmonologist follow-up visit during the month after discharge from the hospital on reducing readmissions.
COPD exacerbations account for 500,000 hospital admissions and $18 billion in direct health-care costs annually. More than half of patients with COPD who are hospitalized due to exacerbations of their condition will be readmitted at least once during the first year after discharge, 14% will be readmitted during the first month after their discharge, and 7% within three months.
Researchers found place of residence was an important factor limiting attendance at follow-up appointments. Patients who lived more than 18 miles from the clinic were less likely to attend the follow up. Patients with large numbers of hospitalizations during the previous year were also less likely to attend follow-up visits. Factors positively influencing attendance at follow-up visits include written recommendations accompanying discharge letters and prehospital admission visits by the patient to a pulmonologist.
"The potential impact of this study on reducing the admission rate of patients with common respiratory diseases is high. Advising a patient to visit a chest physician after discharge may save the next admission and reduce the morbidity burden of this serious disease," said Nimrod Maimon, MD, Department of Medicine and the Pulmonology Institute of Soroka and Ben-Gurion University Medical Center and study author.
American College of Chest Physicians (CHEST), publisher of the journal CHEST, is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care. Its mission is to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. It serves as an essential connection to clinical knowledge and resources for its 18,700 members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For more information about CHEST, visit chestnet.org.